TECX — Tectonic Therapeutic Inc
NASDAQ · Biotechnology · Biotechnology
- Latest Close
- $27.64
- 30-Day Move
- +37.1%
- Market Cap
- $583M
- Shares Outstanding
- 18,780,000
- P/B Ratio
- 1.55
- ROE
- -29.5%
Tectonic Therapeutic Inc
A read-only Alphactor snapshot forTectonic Therapeutic Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$27.64
30-Day Move
+37.1%
Market Cap
$583M
Shares Outstanding
18,780,000
P/B Ratio
1.55
ROE
-29.5%
$27.64
+37.1%last 90 delayed daily bars
90D High
$36.03
90D Low
$16.77
Avg Volume
343,640
TECX is up 37.1% over the last 30 trading days shown on this page.
Latest operating income is $-22M, which helps anchor the headline ratios with an actual earnings figure.
Dark Pool Short %
60.3%
Latest Close
$27.64
30-Day Move
+37.1%
Market Cap
$583M
Shares Outstanding
18,780,000
P/B Ratio
1.55
ROE
-29.5%
ROA
-28.4%
Debt / Equity
0
Current Ratio
26.63
Latest Revenue
$0
Revenue
$0
Gross Profit
--
Operating Income
$-22M
Net Income
$-19M
Gross Margin
--
Net Margin
--
Current Ratio
26.63
Debt / Equity
0.00
Altman Z
34.92
Safe
Piotroski
4
Moderate (4-6)
Cash Conversion
0.81x
Rule of 40
--
Insufficient data
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $0 | $-33M | $-32M | $-30M |
| 2023-12-31 | $0 | $-45M | $-43M | $-41M |
| 2024-12-31 | $0 | $-58M | $-58M | $-59M |
| 2025-12-31 | $0 | $-84M | $-74M | $-60M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| abrdn Healthcare Investors | 770,940 | 0.04% | 2025-12-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 699,971 | 0.04% | 2026-02-28 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 442,889 | 0.02% | 2026-02-28 |
| abrdn Life Sciences Investors | 370,884 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 349,413 | 0.02% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | 266,277 | 0.01% | 2026-02-28 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 245,835 | 0.01% | 2026-02-28 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 190,922 | 0.01% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Qube Research & Technologies
Filed 2025-08-14
--
--
FMR LLC (Fidelity)
Filed 2026-02-17
$59M
+0.0%
Vanguard Group
Filed 2026-01-29
$13M
+5.3%
Farallon Capital
Filed 2026-02-17
$10M
--
Citadel Advisors
Filed 2026-02-17
$7M
--
Geode Capital Management
Filed 2026-02-09
$5M
-2.2%
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.